Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 20/20 | 0.80 |
| ▸ | MMP13 | P45452 | 19/20 | 0.80 |
| ▸ | ADAM17 | P78536 | 18/20 | 0.80 |
| ▸ | MMP9 | P14780 | 5/20 | 0.80 |
| ▸ | MMP2 | P08253 | 3/20 | 0.80 |
| ▸ | MMP3 | P08254 | 4/20 | 0.79 |
| ▸ | ADAM10 | O14672 | 2/20 | 0.79 |
| ▸ | ADAM9 | Q13443 | 2/20 | 0.79 |
| ▸ | MMP7 | P09237 | 2/20 | 0.67 |
| ▸ | MMP8 | P22894 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3947996 | 0.90 | MMP1 (0.83) | MMP1MMP13ADAM17MMP9MMP2 | |
| SCHEMBL2358255 | 0.89 | ADAM17 (1.00) | MMP1MMP13ADAM17MMP9MMP2 | |
| SCHEMBL3942486 | 0.89 | ADAM17 (1.00) | MMP1MMP13ADAM17MMP9MMP2 | |
| SCHEMBL8051411 | 0.89 | MMP1 (0.86) | MMP1MMP13ADAM17MMP9MMP2 | |
| Apratastat SCHEMBL3946334 | 0.88 | MMP1 (1.00) | MMP1MMP13ADAM17MMP9MMP2 | |
| SCHEMBL7325140 | 0.88 | MMP1 (0.86) | MMP1MMP13ADAM17MMP9MMP2 | |
| SCHEMBL3941871 | 0.88 | MMP1 (0.86) | MMP1MMP13ADAM17MMP9MMP2 | |
| SCHEMBL7325752 | 0.88 | MMP1 (0.86) | MMP1MMP13ADAM17MMP9MMP2 | |
| Apratastat SCHEMBL2834310 | 0.88 | MMP1 (1.00) | MMP1MMP13ADAM17MMP9MMP2 | |
| SCHEMBL7317154 | 0.88 | MMP1 (0.80) | MMP1MMP13ADAM17MMP9MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050272725-A1 | Enzymatic process for deacetylation of a phenoxy-alkynyl acetate to the corresponding alcohol | WYETH (US) | 2005-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272725-A1 | Enzymatic process for deacetylation of a phenoxy-alkynyl acetate to the corresponding alcohol | ADH1C, ADH5, ADH1A | MMP1 823/4885MMP13 668/4885ADAM17 1838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.